The Avon, Conn., company's initial guidance for the new year translates to earnings per share ranging from $3.25 to $3.89. It expects revenue between $3.2 billion and $3.4 billion.
Analysts surveyed by FactSet expect, on average, 2012 earnings of $4.07 per share on $3.09 billion in revenue.
Magellan's 2012 projection represents a decrease from the company's 2011 forecast for earnings of $3.75 to $4.36 per share. Analysts expect earnings of $3.87 per share for 2011.
A spokesman for the company said Magellan's 2012 guidance does not factor in share buybacks, which can raise earnings per share by reducing the number of shares. In contrast, the 2011 projection includes share repurchases totaling $398 million through Dec. 12.
The 2012 figure also includes about $27 million in expenses tied to the company's growth pushes in its Medicaid and pharmacy businesses.
The company also said Tuesday that it has a new senior, secured revolving credit line totaling $230 million. That replaces an $80 million facility. Magellan also said it has started buying back shares under a new, $200 million program authorized by its board of directors in October.
Magellan's customers include health plans, employers and government agencies. It manages behavioral health, radiology, specialty pharmaceuticals and public sector pharmacy benefits programs.
Its shares rose $1.96, or 4.1 percent, to $50.03 in premarket trading. For the latest updates on the stock market, visit Stock Market Today
Magellan's 2012 projection, Magellan Health Services Inc stock prices predictions 2012, Magellan shares prices forecast 2012, Magellan market shares 2012 For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment